Gagny, France

Ala-Eddine Deghmane



 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ala-Eddine Deghmane

Introduction

Ala-Eddine Deghmane is a notable inventor based in Gagny, France. He has made significant contributions to the field of immunology, particularly in the development of vaccines. His work focuses on combating serious bacterial infections, showcasing his dedication to public health.

Latest Patents

Ala-Eddine Deghmane holds a patent for a method of immunizing subjects against serogroup X meningococcus. This innovative vaccine comprises one, two, or all three of the following components: a meningococcal fHbp antigen, a meningococcal NHBA antigen, and/or a meningococcal NadA antigen. Additionally, the vaccine may include meningococcal outer membrane vesicles, enhancing its effectiveness in providing immunity.

Career Highlights

Throughout his career, Deghmane has worked with prominent organizations in the pharmaceutical and research sectors. Notably, he has been associated with GlaxoSmithKline Biologicals and Institut Pasteur. His experience in these esteemed institutions has allowed him to contribute to groundbreaking research and development in vaccine technology.

Collaborations

Ala-Eddine Deghmane has collaborated with several professionals in his field, including Mariagrazia Pizza and Peter Dull. These partnerships have facilitated the exchange of ideas and expertise, further advancing the development of innovative solutions in immunization.

Conclusion

Ala-Eddine Deghmane's contributions to vaccine development highlight his commitment to improving public health through innovation. His work in creating effective immunization methods against serogroup X meningococcus is a testament to his expertise and dedication in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…